A Missouri-based gender clinic that's faced government scrutiny this year was the subject of a recent New York Times article looking into a whistleblower's claims that providers were too quick to administer hormone drugs to minor patients amid rising demand in recent years.
The clinic made headlines in February after former case manager Jamie Reed at the Washington University Transgender Center at St. Louis Children's Hospital claimed in a whistleblower affidavit to the state attorney general's office that her former employer pushed puberty-blocking drugs and cross-sex hormones on minors, some of which were reportedly not receiving forced to continue counseling.
Reed claimed that the clinic, which opened in 2017, relied heavily on promoting gender transition for children despite the risks of "permanently harming the vulnerable patients." After an investigation, the university deemed the claims "unsubstantiated."
In a statement to The Christian Post, a spokesperson for Washington University said that an appropriate mental health assessment is required for patient prescriptions, and these assessments are performed by licensed mental health professionals, including at community facilities. Due to patient privacy concerns, the spokesperson could not provide details about specific cases or patients.
"Prescribing decisions reflect individualized assessment, appropriate documentation of consent, discussion of risks such as known side effects and means to avoid those, and an...
Pakistan on April 22, Thursday urged the United Nations to call upon India to restore full implementation of the Indus Waters Treaty (IWT), warning that New Delhi’s “illegal” decision to hold the ...